IOM/SEID vs CCC vs ICC: ME/CFS Diagnostic Criteria Compared

IOM SEID vs CCC vs ICC Criteria — scientific infographic poster

Table of Contents

  1. Why the Criteria You Are Diagnosed Under Matters
  2. Holmes 1988 — The First Case Definition
  3. Fukuda 1994 — The Most Widely Used (and Most Criticized)
  4. Canadian Consensus Criteria (CCC) 2003
  5. International Consensus Criteria (ICC) 2011
  6. IOM/NAM 2015 — SEID and the Push Into Primary Care
  7. Side-by-Side: Sensitivity, Specificity, and What Each One Misses
  8. How to Use a Self-Score Sheet Before Your Appointment
  9. Talking to a Skeptical Primary Care Physician
  10. ICD-10 Coding: G93.32 vs R53.82 and Why It Matters
  11. How the Criteria Compare for Primary Care, Specialists and Disability Claims
  12. Key Research Papers
  13. Connections
  14. Featured Videos

Why the Criteria You Are Diagnosed Under Matters

If you have been sick for months or years with crushing fatigue, brain fog, and a body that punishes you for every step you take, you may have noticed something odd: two doctors can look at the same patient and disagree about whether that patient has myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). One will say yes. The other will shrug and call it "chronic fatigue" or "deconditioning" or "depression with somatic features." They are not necessarily incompetent. They are often using different case definitions.

Over the last forty years, at least five major sets of criteria have been published for what we now usually call myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS). Each set defines the illness differently, captures a different slice of patients, and produces different estimates of how common the disease is. Under one definition your illness counts. Under another it does not. That single fact determines whether you get treated, whether you qualify for disability, whether your insurance covers workup, and whether your family believes you are really sick.

This article walks through the five big criteria sets in the order they were written, explains the trade-offs of each, and gives you a practical way to prepare for an appointment so the doctor across from you can apply them correctly. No criteria set is perfect. But some are far better than others at catching what you actually have.

Holmes 1988 — The First Case Definition

The first formal U.S. case definition came out of the Centers for Disease Control in 1988, led by Gary Holmes. The context matters: in the mid-1980s, clusters of mysteriously exhausted patients were being reported around Lake Tahoe, Nevada, and Lyndonville, New York. Journalists dubbed it "yuppie flu." The U.S. Centers for Disease Control and Prevention (CDC) needed a research definition so epidemiologists could count cases. Holmes and colleagues called the illness chronic fatigue syndrome — a name many patients now consider demeaning, but one that stuck.

The Holmes definition required at least six months of debilitating fatigue that reduced daily activity by at least 50%, plus a long checklist of minor symptoms (sore throat, tender lymph nodes, low-grade fever, muscle pain, joint pain, sleep disturbance, neuropsychological complaints, headaches) and strict exclusions for other medical and psychiatric disease.

It was a research definition, not a clinical one. It missed patients whose fatigue was severe but who did not hit the minor-symptom count, and it completely failed to require the single most defining feature of the illness: post-exertional malaise (PEM). Nobody in 1988 fully understood PEM yet. Holmes was the starting line, not the finish.

Fukuda 1994 — The Most Widely Used (and Most Criticized)

In 1994 the U.S. Centers for Disease Control and Prevention released a revised definition authored by Keiji Fukuda, Stephen Straus, and colleagues. Fukuda 1994 became the dominant criteria set for research studies worldwide for the next two decades, and it is still the one many older primary care physicians learned in training.

Fukuda requires:

Here is the central problem: in Fukuda, PEM is one of eight optional symptoms. A patient can meet Fukuda criteria without having PEM at all, as long as they have enough of the other symptoms. That matters enormously, because PEM — the worsening of all symptoms after minor physical, cognitive, or emotional exertion, often delayed 24–72 hours — is the single feature that distinguishes myalgic encephalomyelitis/chronic fatigue syndrome from depression, deconditioning, burnout, and almost every other fatiguing illness.

Leonard Jason and colleagues at DePaul University showed in multiple studies that Fukuda is so broad it scoops up patients with major depressive disorder who do not have myalgic encephalomyelitis/chronic fatigue syndrome at all. Treatment trials recruited under Fukuda often include a mixed population, which is one reason graded-exercise-therapy studies produced results that harmed real myalgic encephalomyelitis/chronic fatigue syndrome patients: many of the "responders" in those trials may not have had myalgic encephalomyelitis/chronic fatigue syndrome in the first place.

Fukuda is too sensitive and not specific enough. A diagnosis made by Fukuda alone does not establish that PEM is present.

Canadian Consensus Criteria (CCC) 2003

In 2003, an international panel led by Canadian physicians Bruce Carruthers and Anil Kumar Jain published what became known as the Canadian Consensus Criteria. Unlike Holmes and Fukuda, CCC was built as a clinical (not just research) definition, and it was the first major criteria set to put PEM as a required symptom, not an optional one.

To meet CCC, a patient must have:

CCC is sharper. Studies by Jason's group showed it identifies a more homogeneous, more impaired patient group with clearer biological abnormalities than Fukuda. The trade-off is that it is longer to apply in clinic and requires the physician actually to know what PEM is and how to ask about it.

International Consensus Criteria (ICC) 2011

In 2011, a larger international panel — again led by Carruthers — published the International Consensus Criteria. The ICC was deliberately stricter than CCC and, in an act of clinical politics, dropped the name "chronic fatigue syndrome" entirely. The authors argued the illness should be called what the World Health Organization had already classified it as since 1969: myalgic encephalomyelitis.

ICC requires:

Importantly, ICC does not require a six-month waiting period. The authors argued that forcing a sick patient to wait half a year before being evaluated is cruel and clinically counterproductive — early recognition may improve outcomes.

ICC is the most specific of all the major criteria sets. Patients who meet ICC almost certainly have the illness. The downside is that it is long, symptom-heavy, and almost never taught in U.S. medical schools. A family-medicine doctor with a 15-minute appointment slot will not apply ICC. A specialist at a referral myalgic encephalomyelitis/chronic fatigue syndrome clinic might.

IOM/NAM 2015 — SEID and the Push Into Primary Care

In 2015, the U.S. Institute of Medicine (now the National Academy of Medicine) published a landmark report, Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. The committee reviewed more than 9,000 scientific articles and interviewed patients, clinicians, and researchers. Their goal was blunt: create a definition simple enough that primary care physicians would actually use it.

They proposed a new name, Systemic Exertion Intolerance Disease (SEID), and a dramatically streamlined criteria set. The name never caught on — patients and advocacy groups largely rejected it, and most clinicians still say "myalgic encephalomyelitis/chronic fatigue syndrome" — but the criteria themselves have become the de facto U.S. clinical standard, and the U.S. Centers for Disease Control and Prevention's clinician pages state that clinicians can use the IOM criteria to diagnose ME/CFS.

SEID requires all three of the following:

  1. A substantial reduction or impairment in the ability to engage in pre-illness levels of occupational, educational, social, or personal activities, persisting more than six months, accompanied by fatigue (often profound) that is of new or definite onset, not the result of ongoing excessive exertion, and not substantially alleviated by rest.
  2. Post-exertional malaise.
  3. Unrefreshing sleep.

Plus at least one of:

  1. Cognitive impairment (brain fog), OR
  2. Orthostatic intolerance (symptoms worsening when upright).

That is the entire definition. Three core symptoms plus one of two. A busy primary care physician can apply it in a single visit.

SEID kept what CCC and ICC made non-negotiable — PEM is required — while stripping away the long category lists that made the earlier definitions too complicated for general practice. Comparison studies by Leonard Jason and colleagues (2015) found SEID to be broad rather than narrow. In 796 patients from the US, Great Britain and Norway, SEID identified 88% of participants, comparable to the 92% who met Fukuda and a larger group than the Canadian Consensus Criteria or the International Consensus Criteria, and it selected more patients with less impairment and fewer symptoms. Because SEID names few exclusionary illnesses, many people with major depressive disorder and other medical illnesses were also classed as having SEID, and in a community sample the prevalence found under Fukuda rose 2.8 times under SEID.

The IOM criteria are now used in large studies. The U.S. RECOVER-Adult study (2025) used them to count ME/CFS after COVID-19: new ME/CFS appeared at 2.66 per 100 person-years after infection, against 0.93 per 100 person-years in matched uninfected participants (hazard ratio 4.93). In all, 4.5% of infected participants (531 of 11,785) met the criteria after infection, against 0.6% (9 of 1,439) of uninfected participants, and post-exertional malaise was the most common ME/CFS symptom in infected participants (24.0%).

Side-by-Side: Sensitivity, Specificity, and What Each One Misses

No criteria set is perfect, and each one makes trade-offs between catching every real case (sensitivity) and excluding people who have something else (specificity).

The most common real-world mistake: a patient has classic myalgic encephalomyelitis/chronic fatigue syndrome, the primary care physician (PCP) applies Fukuda (or no criteria at all), notes "fatigue and poor sleep," and writes "chronic fatigue" on the chart. That vague label unlocks no treatment, no specialist referral, and no disability support. The same patient evaluated under CCC or SEID with careful questioning about PEM would get a real diagnosis and real help.

How to Use a Self-Score Sheet Before Your Appointment

A short written summary handed to your doctor at the start of a visit is the single most effective way to get an accurate diagnosis. Most physicians have seen fewer than a handful of myalgic encephalomyelitis/chronic fatigue syndrome patients in their career and cannot remember the criteria off the top of their head. Make it easy for them.

Write a one-page sheet that covers:

At the end, write a single line: "Please evaluate me against the 2015 IOM/NAM criteria for ME/CFS (SEID) and/or the Canadian Consensus Criteria." That one line tells the doctor which ruler to use.

Talking to a Skeptical Primary Care Physician

If your physician pushes back — "this is just depression," "you need to exercise more," "everyone is tired" — patients and advocates describe several approaches that keep the conversation calm and away from an argument.

ICD-10 Coding: G93.32 vs R53.82 and Why It Matters

The diagnosis code on your chart determines how the medical system treats you — literally and administratively. There are two codes you may see, and they are not equivalent.

Why the distinction matters in practice:

When a chart shows R53.82 and the patient meets CCC, ICC, or SEID criteria, the patient can ask the physician to update the diagnosis to G93.32, with the self-score sheet as support. This is a small administrative change that can meaningfully improve what the rest of the system will do for you.

How the Criteria Compare for Primary Care, Specialists and Disability Claims

How the criteria are used in U.S. care today:

Your diagnosis is a paperwork decision with medical consequences. The criteria and the ICD-10 code your doctor writes down will shape every conversation with every clinician, insurer, and disability examiner who comes after. A little preparation before the appointment pays back for years.

Key Research Papers

  1. Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. National Academies Press, 2015. — doi:10.17226/19012 (IOM/SEID criteria)
  2. Carruthers BM, et al. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med. 2011;270(4):327–338. — doi:10.1111/j.1365-2796.2011.02428.x
  3. Carruthers BM, et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols (Canadian Consensus Criteria). J Chronic Fatigue Syndr. 2003;11(1):7–115. — doi:10.1300/J092v11n01_02
  4. Fukuda K, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med. 1994;121(12):953–959. — doi:10.7326/0003-4819-121-12-199412150-00009
  5. Jason LA, Sunnquist M, Brown A, Newton JL, Strand EB, Vernon SD. Chronic Fatigue Syndrome versus Systemic Exertion Intolerance Disease. Fatigue. 2015;3(3):127–141. — doi:10.1080/21641846.2015.1051291
  6. Jason LA, Sunnquist M, Kot B, Brown A. Unintended Consequences of not Specifying Exclusionary Illnesses for Systemic Exertion Intolerance Disease. Diagnostics (Basel). 2015;5(2):272–286. — doi:10.3390/diagnostics5020272
  7. Lim EJ, Kang EB, Jang ES, Son CG. The Prospects of the Two-Day Cardiopulmonary Exercise Test (CPET) in ME/CFS Patients: A Meta-Analysis. J Clin Med. 2020;9(12):4040. — doi:10.3390/jcm9124040
  8. Vernon SD, Zheng T, Do H, Marconi VC, Jason LA, Singer NG, Natelson BH, Sherif ZA, Bonilla HF, Taylor E, Mullington JM, Ashktorab H, Laiyemo AO, Brim H, Patterson TF, Akintonwa TT, Sekar A, Peluso MJ, Maniar N, Bateman L, Horwitz LI, Hess R; NIH Researching COVID to Enhance Recovery (RECOVER) Consortium. Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study. J Gen Intern Med. 2025;40(5):1085–1094. — doi:10.1007/s11606-024-09290-9

PubMed Topic Searches

For further reading, the following PubMed topic searches return current peer-reviewed work on myalgic encephalomyelitis/chronic fatigue syndrome case definitions, diagnostic accuracy, and coding:

  1. PubMed: IOM/SEID criteria for ME/CFS
  2. PubMed: Canadian Consensus Criteria for ME
  3. PubMed: International Consensus Criteria for ME
  4. PubMed: Fukuda criteria — comparisons and critiques
  5. PubMed: Post-exertional malaise in diagnostic criteria
  6. PubMed: Sensitivity and specificity of ME/CFS case definitions
  7. PubMed: ICD-10 coding (G93.3) in ME/CFS
  8. PubMed: Jason and colleagues — criteria comparison studies

Back to Table of Contents

Connections

Back to Table of Contents